Quality of life instruments in oncology.

The objective of this article is to aid clinicians in understanding the current state of the development and application of quality of life (QOL) instruments as outcome measures in cancer clinical research and practice. As a result of the achievements of the past two decades, the concept of QOL has been defined and many reliable and valid measurement tools have been developed. The two main approaches to QOL assessment, psychometric-based and utility-based, are discussed together with a brief description of the strategies for meaningful interpretation of QOL profiles. QOL measures in oncology have the potential to be used to study populations in randomised clinical trials, to aid patient-clinician interactions in routine practice and to support policy decision making and economic evaluation of healthcare provision.

[1]  W. Gregory,et al.  Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. , 1990, BMJ.

[2]  N. Aaronson,et al.  A modular approach to quality-of-life assessment in cancer clinical trials. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[3]  D. Osoba,et al.  Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  T. Ibbotson,et al.  Screening for anxiety and depression in cancer patients: the effects of disease and treatment. , 1994, European journal of cancer.

[6]  B. Rittenhouse,et al.  Healthy Years Equivalents Versus Time Trade-off: Ambiguity on Certainty and Uncertainty , 1997, International Journal of Technology Assessment in Health Care.

[7]  G. Browman,et al.  Science, language, intuition, and the many meanings of quality of life. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  W. Zung A SELF-RATING DEPRESSION SCALE. , 1965, Archives of general psychiatry.

[9]  D. Razavi,et al.  Communication skills and psychological training in oncology. , 1997, European journal of cancer.

[10]  John E. Ware,et al.  SF-36 physical and mental health summary scales : a user's manual , 1994 .

[11]  A. Williams EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[12]  C Safran,et al.  Patient entries in the electronic medical record: an interactive interview used in primary care. , 1995, Proceedings. Symposium on Computer Applications in Medical Care.

[13]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[14]  J. Davies Data Protection Act and medical records , 1985 .

[15]  C. McHorney,et al.  Generic Health Measurement: Past Accomplishments and a Measurement Paradigm for the 21st Century , 1997, Annals of Internal Medicine.

[16]  Improving Patient Function , 1989 .

[17]  P. Novotny,et al.  Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S M Gore,et al.  Quality of life measures in health care. III: Resource allocation. , 1992, BMJ.

[19]  Richard D. Gelber,et al.  A quality-of-life-oriented endpoint for comparing therapies. , 1989 .

[20]  A. Howell,et al.  Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. , 1991, British Journal of Cancer.

[21]  R. Brooks EuroQol: the current state of play. , 1996, Health policy.

[22]  R. Fitzpatrick,et al.  Health economics and quality of life in cancer trials: report based on a UKCCCR workshop. United Kingdom Coordinating Committee on Cancer Research. , 1998, British Journal of Cancer.

[23]  B. Mount,et al.  Existential well‐being is an important determinant of quality of life: Evidence from the McGill quality of life questionnaire , 1996, Cancer.

[24]  S. Greenfield,et al.  Recent developments and future issues in the use of health status assessment measures in clinical settings. , 1992, Medical care.

[25]  R. Gelber,et al.  Quality-of-life assessment in clinical trials. , 1995, Cancer treatment and research.

[26]  L. Påhlman,et al.  Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens. , 1989, European journal of cancer & clinical oncology.

[27]  F. WislØff,et al.  Health‐related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma , 1997, British journal of haematology.

[28]  M. Weinstein,et al.  Performance of a Five-Item Mental Health Screening Test , 1991, Medical care.

[29]  G. Guyatt,et al.  Quality of life in stage II breast cancer: an instrument for clinical trials. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D. Haes Quality of Life: Conceptual and theoretical considerations , 1988 .

[31]  M. Atkinson,et al.  Computerized quality-of-life screening in an oncology clinic. , 1997, Cancer practice.

[32]  A. Williams Economics of coronary artery bypass grafting. , 1985, British medical journal.

[33]  J. Brazier,et al.  Deriving a preference-based single index from the UK SF-36 Health Survey. , 1998, Journal of clinical epidemiology.

[34]  D. Osoba Self-rating symptom checklists: a simple method for recording and evaluating symptom control in oncology. , 1993, Cancer treatment reviews.

[35]  R. Kane,et al.  Methodology for measuring health-state preferences--II: Scaling methods. , 1989, Journal of clinical epidemiology.

[36]  L E Kazis,et al.  Health status reports in the care of patients with rheumatoid arthritis. , 1990, Journal of clinical epidemiology.

[37]  R. Temple,et al.  Food and Drug Administration requirements for approval of new anticancer drugs. , 1985, Cancer treatment reports.

[38]  P. Hersey,et al.  Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. , 1993, European journal of cancer.

[39]  R. Gelber,et al.  Evaluation of effectiveness: Q-TWiST , 1993 .

[40]  D. Osoba,et al.  Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials Group. , 1996, Journal of the National Cancer Institute. Monographs.

[41]  Moira Stewart,et al.  Communicating with medical patients , 1989 .

[42]  J. Vaeth Body image, self-esteem, and sexuality in cancer patients , 1983 .

[43]  G. Guyatt,et al.  Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop. , 1998, European journal of cancer.

[44]  Types of economic evaluation , 1999 .

[45]  D A Revicki,et al.  Relationship between health utility and psychometric health status measures. , 1992, Medical care.

[46]  S. Palmer,et al.  Economics notes: types of economic evaluation. , 1999, BMJ.

[47]  K Magruder-Habib,et al.  Improving Physicians' Recognition and Treatment of Depression in General Medical Care: Results From a Randomized Clinical Trial , 1990, Medical care.

[48]  P. Fayers,et al.  Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience , 1997 .

[49]  A McMurray,et al.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  J. de Haes,et al.  Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. , 1990, British Journal of Cancer.

[51]  P. Ganz,et al.  CAncer rehabilitation evaluation system–short form (CARES‐SF). A cancer specific rehabilitation and quality of life instrument , 1991, Cancer.

[52]  G. Guyatt,et al.  Assessing the minimal important difference in symptoms: a comparison of two techniques. , 1996, Journal of clinical epidemiology.

[53]  T. Young,et al.  The use of the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-C30 questionnaires to screen for treatable unmet needs in patients attending routinely for radiotherapy. , 1996, Cancer treatment reviews.

[54]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[55]  R. Snaith,et al.  The Hospital Anxiety and Depression Scale , 1983 .

[56]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  S. Passik,et al.  Oncologists' recognition of depression in their patients with cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  R. Goeree,et al.  The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada. , 1992, Social science & medicine.

[59]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[60]  P S Kurtin,et al.  Monitoring dialysis patients' health status. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[61]  D. Osoba,et al.  Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  L. Holmberg,et al.  The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[63]  D. Forman,et al.  Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  D. Osoba,et al.  Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. , 1997, European journal of cancer.

[65]  J F Forbes,et al.  Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  M. Tattersall,et al.  Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. , 1987, The New England journal of medicine.

[67]  D. Osoba Lessons learned from measuring health-related quality of life in oncology. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  M. McGurk,et al.  Attitudes to chemotherapy. , 1990, BMJ.

[69]  P. Ganz Quality of life and the patient with cancer. Individual and policy implications , 1994 .

[70]  P Glasziou,et al.  Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  A. Jette,et al.  Improving patient function: a randomized trial of functional disability screening. , 1989, Annals of internal medicine.

[72]  L. Fallowfield,et al.  Teaching senior oncologists communication skills: results from phase I of a comprehensive longitudinal program in the United Kingdom. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.

[74]  I. Thompson,et al.  Quality of life assessment in Southwest Oncology Group trials. , 1990, Oncology.

[75]  A. Dobson,et al.  Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. , 1981, Journal of chronic diseases.

[76]  N K Aaronson,et al.  Quality of life assessment in daily clinical oncology practice: a feasibility study. , 1998, European journal of cancer.

[77]  L. Fallowfield,et al.  Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? , 1999, European journal of cancer.

[78]  P. Fayers,et al.  Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  G. Loomes,et al.  The use of QALYs in health care decision making. , 1989, Social science & medicine.

[80]  B. Meyerowitz Quality of life in breast cancer patients: the contribution of data to the care of patients. , 1993, European journal of cancer.

[81]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[82]  M. Drummond,et al.  Trials and Tribulations: Emerging Issues in Designing Economic Evaluations Alongside Clinical Trials , 1998, International Journal of Technology Assessment in Health Care.

[83]  R A Deyo,et al.  Strategies for improving and expanding the application of health status measures in clinical settings. A researcher-developer viewpoint. , 1992, Medical care.

[84]  J. Mcewen The Nottingham Health Profile , 1993 .

[85]  R L Kane,et al.  Methodology for measuring health-state preferences--IV: Progress and a research agenda. , 1989, Journal of clinical epidemiology.

[86]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[87]  A. Coates,et al.  On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. , 1983, European journal of cancer & clinical oncology.

[88]  R. Deyo,et al.  Barriers to the Use of Health Status Measures in Clinical Investigation, Patient Care, and Policy Research , 1989, Medical care.

[89]  H. Fukuda,et al.  European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Blood 2008; 112(5):1600-9 , 2022 .

[90]  M. Watson,et al.  The Factor Structure and Factor Stability of the Hospital Anxiety and Depression Scale in Patients with Cancer , 1991, British Journal of Psychiatry.

[91]  Cella Df,et al.  Quality of life during and after cancer treatment. , 1988 .

[92]  D. Goldberg,et al.  A scaled version of the General Health Questionnaire , 1979, Psychological Medicine.

[93]  S P McKenna,et al.  The Nottingham Health Profile: subjective health status and medical consultations. , 1981, Social science & medicine. Part A, Medical sociology.

[94]  G. Torrance Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[95]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. , 1998 .

[96]  J E Ware,et al.  Measuring patients' views: the optimum outcome measure. , 1993, BMJ.

[97]  R. Gelber,et al.  Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  W. Gregory,et al.  Who should measure quality of life, the doctor or the patient? , 1988, British Journal of Cancer.